Artículos del autor

solaci

Mitral valve

Bad prognosis for post-MitraClip mitral valve stenosis: how do we proceed?

Courtesy of Dr. Carlos Fava The EVEREST II trial showed the MitraClip had similar mortality rate to that...
solaci -
Acute coronary syndromes

DEFINE FLAIR and IFR SWEDEHEART: Safety in Revascularization Based on FFR and iFR in Both Stable and ACS Patients

The safety of physiology-based coronary revascularisation has been supported by evidence for years now. DEFER (1998-2001) was...
solaci -
Coronary disease

DESSOLVE III: Xience vs. MiStent

The MiStent device is made of cobalt-chromium, with struts of up to 64 µm thick. It is coated...
solaci -
DAY 1

REPRISE III: Lotus and CoreValve Compared in High-Risk or Inoperable Patients

The efficacy of transcatheter aortic valve replacement (TAVR) has been well-established. However, its limitations include suboptimal deployment...
solaci -
Antiplatelet

TOPIC: Benefits of Switching Dual Antiplatelet Therapy in Patients with ACS

Newer P2Y12 blockers are the front-line treatment and dual antiplatelet therapy is indicated for 1 year after acute...
solaci -
Peripheral vascular disease

Missed Opportunities with Patients with Peripheral Vascular Disease

Little is known about how good are our counseling efforts on medication use and lifestyle as regards...
solaci -
Carotid

Plaque protrusion in carotid artery stenting: what are its risks and how can we prevent them?

Courtesy of Dr. Carlos Fava. Carotid artery stenting (CAS) has proven to be effective in high-risk patients. Nowadays, when...
solaci -
Structural heart disease

Further Evidence on Managing Dysfunctioning Bioprostheses with Balloon-Expandable Prostheses

Early experience with the valve-in-valve technique in the treatment of failed bioprosthetic surgical valves in transcatheter aortic...
solaci -